Brazil well being regulator Anvisa on Friday mentioned it had authorized use of the Pfizer/BioNtech COVID-19 vaccine for youngsters over 12 years of age.
Anvisa mentioned it authorized the measure after seeing research, carried out exterior Brazil, that confirmed security and efficacy for the age group.
The vaccine, the primary in Brazil to obtain definitive approval from Anvisa, was already approved to be used on adolescents aged 16 and over, the regulator mentioned. It added that the Pfizer vaccine was presently the one one approved for use on minors.
Our Requirements: The Thomson Reuters Trust Principles.